JAZZ
Jazz Pharmaceuticals PLC
NASDAQ: JAZZ · HEALTHCARE · BIOTECHNOLOGY
$205.06
-0.83% today
Updated 2026-10-28
Market cap
$13.65B
P/E ratio
14.70
P/S ratio
2.97x
EPS (TTM)
$14.30
Dividend yield
—
52W range
$129 – $266
Volume
0.9M
Jazz Pharmaceuticals PLC (JAZZ) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$205.06
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$342.46
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $3.7B | $3.8B | $4.1B | $4.3B | $4.8B | $5.4B | $6.1B | $6.8B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 12.54% (capped 20%) · P/E: 14.70x (capped 25x) · Margin: 20.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.